Diabetic cardiomyopathy is also associated with alterations in titin phosphorylation, and common diabetic drugs, such as metformin, have been identified to alter titin phosphorylation, enhancing diastolic compliance. This evidence concerns the gene TTN and diabetic cardiomyopathy.